Sai Life Sciences Ltd. operates as a contract research, development, and manufacturing organization. The company is headquartered in Hyderabad, Telangana and currently employs 3,401 full-time employees. The company went IPO on 2024-12-18. The firm carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. The company is engaged in offering a range of services tailor-made to the customer's requirements. The company provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.